MacroGenics (NASDAQ:MGNX – Free Report) had its target price raised by JMP Securities from $10.00 to $16.00 in a report released on Wednesday, Benzinga reports. They currently have a market outperform rating on the biopharmaceutical company’s stock. Several other equities analysts have also recently issued reports on the company. StockNews.com cut MacroGenics from a buy […]
Hobart Private Capital LLC increased its position in SPDR S&P Semiconductor ETF (NYSEARCA:XSD – Free Report) by 1.4% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 51,417 shares of the company’s stock after purchasing an additional 724 shares during the period. […]
StockNews.com cut shares of Syros Pharmaceuticals (NASDAQ:SYRS – Free Report) from a hold rating to a sell rating in a report published on Tuesday morning. Separately, Piper Sandler dropped their price objective on shares of Syros Pharmaceuticals from $11.00 to $7.00 and set an overweight rating on the stock in a research report on Tuesday, […]
Purple Innovation (NASDAQ:PRPL) PT Lowered to $5 00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Aemetis (NASDAQ:AMTX – Free Report) had its price target increased by Stifel Nicolaus from $7.50 to $8.00 in a research report released on Tuesday, Benzinga reports. The brokerage currently has a buy rating on the specialty chemicals company’s stock. Aemetis Trading Up 0.4 % Shares of NASDAQ AMTX opened at $3.47 on Tuesday. Aemetis has […]